JPMorgan Chase & Co’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$48.1M Sell
220,044
-435,132
-66% -$95.2M ﹤0.01% 1229
2025
Q1
$147M Sell
655,176
-153,497
-19% -$34.4M 0.01% 725
2024
Q4
$265M Sell
808,673
-159,745
-16% -$52.3M 0.02% 534
2024
Q3
$291M Buy
968,418
+55,836
+6% +$16.8M 0.02% 527
2024
Q2
$301M Sell
912,582
-92,832
-9% -$30.6M 0.02% 470
2024
Q1
$398M Buy
1,005,414
+125,345
+14% +$49.6M 0.03% 421
2023
Q4
$310M Sell
880,069
-29,842
-3% -$10.5M 0.03% 447
2023
Q3
$341M Sell
909,911
-36,369
-4% -$13.6M 0.04% 380
2023
Q2
$362M Buy
946,280
+97,014
+11% +$37.1M 0.04% 369
2023
Q1
$294M Buy
849,266
+359,021
+73% +$124M 0.04% 394
2022
Q4
$115M Buy
490,245
+268,770
+121% +$63.3M 0.02% 669
2022
Q3
$54.5M Sell
221,475
-6,100
-3% -$1.5M 0.01% 925
2022
Q2
$68.8M Sell
227,575
-64,200
-22% -$19.4M 0.01% 845
2022
Q1
$120M Buy
291,775
+15,102
+5% +$6.2M 0.01% 724
2021
Q4
$130M Buy
276,673
+42,773
+18% +$20.1M 0.02% 705
2021
Q3
$99.3M Sell
233,900
-80,969
-26% -$34.4M 0.01% 815
2021
Q2
$113M Sell
314,869
-4,806
-2% -$1.73M 0.01% 788
2021
Q1
$90.1M Buy
319,675
+67,607
+27% +$19.1M 0.01% 837
2020
Q4
$71.4M Sell
252,068
-109,374
-30% -$31M 0.01% 844
2020
Q3
$98.9M Sell
361,442
-448,955
-55% -$123M 0.02% 653
2020
Q2
$184M Sell
810,397
-176,120
-18% -$40M 0.04% 440
2020
Q1
$150M Sell
986,517
-364,320
-27% -$55.5M 0.04% 433
2019
Q4
$203M Sell
1,350,837
-170,166
-11% -$25.6M 0.04% 393
2019
Q3
$216M Sell
1,521,003
-30,527
-2% -$4.33M 0.04% 397
2019
Q2
$192M Sell
1,551,530
-2,470
-0.2% -$305K 0.04% 438
2019
Q1
$171M Sell
1,554,000
-67,780
-4% -$7.47M 0.04% 451
2018
Q4
$159M Sell
1,621,780
-17,174
-1% -$1.68M 0.04% 435
2018
Q3
$202M Sell
1,638,954
-202,576
-11% -$25M 0.04% 430
2018
Q2
$183M Sell
1,841,530
-8,023
-0.4% -$797K 0.04% 433
2018
Q1
$163M Sell
1,849,553
-2,069
-0.1% -$183K 0.04% 449
2017
Q4
$183M Buy
1,851,622
+4,151
+0.2% +$410K 0.04% 414
2017
Q3
$178M Sell
1,847,471
-161,935
-8% -$15.6M 0.04% 420
2017
Q2
$190M Sell
2,009,406
-22,176
-1% -$2.1M 0.04% 394
2017
Q1
$166M Buy
2,031,582
+186,692
+10% +$15.2M 0.04% 420
2016
Q4
$157M Buy
1,844,890
+485,073
+36% +$41.1M 0.04% 413
2016
Q3
$101M Buy
1,359,817
+86,470
+7% +$6.44M 0.02% 510
2016
Q2
$96.6M Buy
1,273,347
+111,645
+10% +$8.47M 0.02% 524
2016
Q1
$80.5M Buy
1,161,702
+47,312
+4% +$3.28M 0.02% 556
2015
Q4
$67.1M Sell
1,114,390
-153,428
-12% -$9.24M 0.02% 635
2015
Q3
$68.6M Sell
1,267,818
-19,765
-2% -$1.07M 0.02% 622
2015
Q2
$74.8M Sell
1,287,583
-21,360
-2% -$1.24M 0.02% 670
2015
Q1
$78.8M Buy
1,308,943
+87,421
+7% +$5.26M 0.02% 675
2014
Q4
$65M Buy
1,221,522
+27,867
+2% +$1.48M 0.01% 748
2014
Q3
$53.4M Buy
1,193,655
+11,992
+1% +$537K 0.01% 792
2014
Q2
$49.8M Buy
1,181,663
+180,406
+18% +$7.61M 0.01% 838
2014
Q1
$44.1M Buy
1,001,257
+575,228
+135% +$25.3M 0.01% 853
2013
Q4
$20.9M Buy
426,029
+13,441
+3% +$659K 0.01% 1227
2013
Q3
$17M Buy
412,588
+299,876
+266% +$12.3M 0.01% 1350
2013
Q2
$3.96M Buy
+112,712
New +$3.96M ﹤0.01% 2100